CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+9.19%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$709M
AUM Growth
+$709M
(-9.9%)
Cap. Flow
-$72.4M
Cap. Flow
% of AUM
-10.22%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
452
New
12
Increased
93
Reduced
281
Closed
40
Top Buys
| 1 |
NVIDIA
NVDA
|
$40.6M |
| 2 |
Apple
AAPL
|
$9.08M |
| 3 |
Applied Materials
AMAT
|
$5.39M |
| 4 |
Arista Networks
ANET
|
$5.26M |
| 5 |
Amphenol
APH
|
$5.14M |
Top Sells
| 1 |
Amgen
AMGN
|
$8.02M |
| 2 |
Adobe
ADBE
|
$7.95M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$7.6M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$6.84M |
| 5 |
Lam Research
LRCX
|
$5.23M |
Sector Composition
| 1 | Technology | 43.87% |
| 2 | Healthcare | 22.25% |
| 3 | Consumer Discretionary | 12.69% |
| 4 | Communication Services | 10.44% |
| 5 | Consumer Staples | 3.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
AbbVie
ABBV
$374B
| $470K | 0.07% |
2,742
-803
| -23% | -$138K |
|
152
Merus
MRUS
$5.01B
| $461K | 0.07% |
7,783
-3,330
| -30% | -$197K |
|
153
Avidity Biosciences
RNA
$6.08B
| $459K | 0.06% |
11,235
-4,064
| -27% | -$166K |
|
154
Immunovant
IMVT
$2.63B
| $453K | 0.06% |
17,160
-10,776
| -39% | -$284K |
|
155
Axsome Therapeutics
AXSM
$6.16B
| $449K | 0.06% |
5,580
-3,523
| -39% | -$284K |
|
156
Bank of America
BAC
$373B
| $437K | 0.06% |
10,999
-3,301
| -23% | -$131K |
|
157
Cintas
CTAS
$82.8B
| $427K | 0.06% |
610
+153
| +33% | +$107K |
|
158
Chevron
CVX
$326B
| $425K | 0.06% |
2,718
-872
| -24% | -$136K |
|
159
Legend Biotech
LEGN
$6.32B
| $425K | 0.06% |
9,597
-5,695
| -37% | -$252K |
|
160
Guardant Health
GH
$8.29B
| $415K | 0.06% |
14,378
-9,028
| -39% | -$261K |
|
161
Marriott International Class A Common Stock
MAR
$71.8B
| $415K | 0.06% |
1,717
+411
| +31% | +$99.4K |
|
162
Crinetics Pharmaceuticals
CRNX
$3.14B
| $415K | 0.06% |
9,265
-4,099
| -31% | -$184K |
|
163
NXP Semiconductors
NXPI
$58.7B
| $415K | 0.06% |
1,537
+380
| +33% | +$103K |
|
164
Dyne Therapeutics
DYN
$1.92B
| $406K | 0.06% |
11,498
-4,075
| -26% | -$144K |
|
165
Airbnb
ABNB
$78.1B
| $402K | 0.06% |
2,654
-840
| -24% | -$127K |
|
166
Ultragenyx Pharmaceutical
RARE
$3.09B
| $401K | 0.06% |
9,766
-6,051
| -38% | -$249K |
|
167
CSX Corp
CSX
$60B
| $393K | 0.06% |
11,754
+2,917
| +33% | +$97.6K |
|
168
Denali Therapeutics
DNLI
$2.26B
| $389K | 0.05% |
16,753
-9,968
| -37% | -$231K |
|
169
Constellation Energy
CEG
$96B
| $380K | 0.05% |
1,895
+467
| +33% | +$93.5K |
|
170
Arrowhead Research
ARWR
$3.55B
| $379K | 0.05% |
14,592
-9,246
| -39% | -$240K |
|
171
O'Reilly Automotive
ORLY
$87.6B
| $374K | 0.05% |
354
+88
| +33% | +$92.9K |
|
172
PayPal
PYPL
$66.2B
| $365K | 0.05% |
6,289
-3,389
| -35% | -$197K |
|
173
Roper Technologies
ROP
$55.9B
| $363K | 0.05% |
644
+161
| +33% | +$90.7K |
|
174
Oracle
ORCL
$633B
| $361K | 0.05% |
2,554
-758
| -23% | -$107K |
|
|
CTLT
175
DELISTED
CATALENT, INC.
CTLT
| $354K | 0.05% |
6,301
| – | – |
|